Table 7.
Bivariate Results: Current HIV Medication-Taking Characteristics That Are Statistically Significantly Correlated (p < .05) with Increased Likelihood to Switch to a New HIV Remission Strategy in Scenarios 1–7
| |
Increased likelihood of choosing new HIV remission strategy over standard daily ART if… |
||||||
|---|---|---|---|---|---|---|---|
| Characteristic | No more daily pills, but must go to lab/clinic much more often (e.g., every 2 weeks) [Scenario 1] | No more daily pills, but very small increase in chance of passing HIV on to sex partner [Scenario 2] | New strategy causes worse side effects initially but went away eventually [Scenario 3] | Never take HIV medications again, but very small increase in risk of health problems (e.g., cancer) [Scenario 4] | Uncertainty of new strategy working, but need to stop taking the HIV medication to find out [Scenario 5] | New strategy might not increase life expectancy [Scenario 6] | New strategy might not increase quality of life [Scenario 7] |
| No. of ART pills or tablets taken per day | Taking 4+ daily pills (OR = 4.45) more likely to choose HIV remission than 0–1 daily pill-takers | Taking 2–3 daily pills (OR = 2.06) more likely to choose HIV remission than 0–1 daily pill-takers | |||||
| Frequency of taking ART pills or tablets | Taking pills twice or more daily (OR = 2.47) more likely to choose HIV remission than those taking pills only once | ||||||
| Attitude toward current ART medication | People worried about being able to afford and have access to medication (OR = 1.65) more likely to choose HIV remission than people not worried | People feeling that taking ART medication makes them feel in control of their lives (OR = 0.54) less likely to choose HIV remission than those not feeling the same way about ART medication | |||||
| Side effects of current ART medication | Have side effects that are not very bothersome (OR = 1.76) more likely to choose HIV remission than those without any side effects | Have side effects that are not very bothersome (OR = 1.88) more likely to choose HIV remission than those without any side effects | |||||
| Anxiety toward trying HIV remission not working | Feeling anxious (OR = 0.57) less likely to choose HIV remission than those not feeling anxious | Feeling anxious (OR = 0.59) less likely to choose HIV remission than those not feeling anxious | Feeling anxious (OR = 0.50) less likely to choose HIV remission than those not feeling anxious | ||||
| Anxiety toward side effects of HIV remission | Worried about side effects (OR = 0.61) less likely to choose HIV remission than those not worried | Worried about side effects (OR = 0.51) less likely to choose HIV remission than those not worried | Worried about side effects (OR = 0.56) less likely to choose HIV remission than those not worried | Worried about side effects (OR = 0.52) less likely to choose HIV remission than those not worried | Worried about side effects (OR = 0.47) less likely to choose HIV remission than those not worried | Worried about side effects (OR = 0.39) less likely to choose HIV remission than those not worried | Worried about side effects (OR = 0.38) less likely to choose HIV remission that those not worried |
| Willingness to try HIV remission to avoid long-term consequences of HIV treatment | People willing (OR = 12.29) more likely to choose HIV remission than those not willing | People willing (OR = 9.65) more likely to choose HIV remission than those not willing | People willing (OR = 3.22) more likely to choose HIV remission than those not willing | People willing (OR = 2.71) more likely to choose HIV remission than those not willing | |||
Whether timing of ART is affected by food or other drugs and remembering to take current ART medication on time are not statistically significantly correlated with increased likelihood of switching to new HIV remission strategy in scenarios 1–7.